Gilead CEO Daniel O'Day on new HIV prevention medicine: It's going to change the face of HIV

CNBC’s Angelica Peebles and Gilead chairman and CEO Daniel O’Day join ‘Squawk Box’ to discuss the company’s new HIV prevention medicine, impact of the incoming Trump administration on health care, and more.

Source link